924
Views
17
CrossRef citations to date
0
Altmetric
Research Article

Lenalidomide consolidation and maintenance therapy after autologous stem cell transplant for multiple myeloma induces persistent changes in T-cell homeostasis

, , , , , , , , , & show all
Pages 1788-1795 | Received 26 Jun 2013, Accepted 09 Nov 2013, Published online: 31 Dec 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Benjamin W. Teh, Simon J. Harrison, Leon J. Worth & Monica A. Slavin. (2016) Antiviral prophylaxis for varicella zoster virus infections in patients with myeloma in the era of novel therapies. Leukemia & Lymphoma 57:7, pages 1719-1722.
Read now
Isabelle Krämer, Melanie Engelhardt, Sabrina Fichtner, Brigitte Neuber, Sergej Medenhoff, Uta Bertsch, Jens Hillengass, Marc-Steffen Raab, Dirk Hose, Anthony D. Ho, Hartmut Goldschmidt & Michael Hundemer. (2016) Lenalidomide enhances myeloma-specific T-cell responses in vivo and in vitro. OncoImmunology 5:5.
Read now
Xiaoping Liu, Colin K He, Xiangyu Meng, Li He, Kaili Li, Qing Liang, Liang Shao & Shangqin Liu. (2015) Bortezomib-based vs non-bortezomib-based post-transplantation treatment in multiple myeloma patients: a systematic review and meta-analysis of Phase III randomized controlled trials. OncoTargets and Therapy 8, pages 1459-1469.
Read now
Chava Perry & Aaron Polliack. (2014) Lenalidomide and T-cell homeostasis: tolerating immune reconstitution after autologous stem cell transplant. Leukemia & Lymphoma 55:8, pages 1699-1700.
Read now

Articles from other publishers (13)

Murali Janakiram, Nivedita Arora, Veronika Bachanova & Jeffrey S. Miller. (2022) Novel Cell and Immune Engagers in Optimizing Tumor- Specific Immunity Post-Autologous Transplantation in Multiple Myeloma. Transplantation and Cellular Therapy 28:2, pages 61-69.
Crossref
Criselle D'Souza, H. Miles Prince & Paul J. Neeson. (2021) Understanding the Role of T-Cells in the Antimyeloma Effect of Immunomodulatory Drugs. Frontiers in Immunology 12.
Crossref
Joshua F. Zeidner, Hanna A. Knaus, Amer M. Zeidan, Amanda L. Blackford, Raul Montiel-Esparza, Hubert Hackl, Gabrielle T. Prince, Lukasz P. Gondek, Gabriel Ghiaur, Margaret M. Showel, Amy E. DeZern, Keith W. Pratz, B. Douglas Smith, Mark J. Levis, Steven Gore, Catherine C. Coombs, Matthew C. Foster, Howard Streicher, Judith E. Karp, Leo Luznik & Ivana Gojo. (2020) Immunomodulation with pomalidomide at early lymphocyte recovery after induction chemotherapy in newly diagnosed AML and high-risk MDS. Leukemia 34:6, pages 1563-1576.
Crossref
Sophia Danhof, Susanne Strifler, Dorothea Hose, Martin Kortüm, Max Bittrich, Jochen Hefner, Hermann Einsele, Stefan Knop & Martin Schreder. (2018) Clinical and biological characteristics of myeloma patients influence response to elotuzumab combination therapy. Journal of Cancer Research and Clinical Oncology 145:3, pages 561-571.
Crossref
Giulia Di Lullo, Magda Marcatti, Silvia Heltai, Cristina Tresoldi, Anna Maria Paganoni, Claudio Bordignon, Fabio Ciceri & Maria Pia Protti. (2019) Immunomodulatory Drugs in the Context of Autologous Hematopoietic Stem Cell Transplantation Associate With Reduced Pro-tumor T Cell Subsets in Multiple Myeloma. Frontiers in Immunology 9.
Crossref
Karel Fostier, Jo Caers, Nathalie Meuleman, Katrijn Broos, Jurgen Corthals, Kris Thielemans, Rik Schots & Brenda De Keersmaecker. (2018) Impact of lenalidomide maintenance on the immune environment of multiple myeloma patients with low tumor burden after autologous stem cell transplantation. Oncotarget 9:29, pages 20476-20489.
Crossref
Xiuli Wang, Miriam Walter, Ryan Urak, Lihong Weng, Christian Huynh, Laura Lim, ChingLam W. Wong, Wen-Chung Chang, Sandra H. Thomas, James F. Sanchez, Lu Yang, Christine E. Brown, Flavia Pichiorri, Myo Htut, Amrita Y. Krishnan & Stephen J. Forman. (2018) Lenalidomide Enhances the Function of CS1 Chimeric Antigen Receptor–Redirected T Cells Against Multiple Myeloma. Clinical Cancer Research 24:1, pages 106-119.
Crossref
Brigitte Neuber, Jingying Dai, Wjahat A. Waraich, Mohamed H.S. Awwad, Melanie Engelhardt, Michael Schmitt, Sergej Medenhoff, Mathias Witzens-Harig, Anthony D. Ho, Hartmut Goldschmidt & Michael Hundemer. (2017) Lenalidomide overcomes the immunosuppression of regulatory CD8+CD28− T-cells. Oncotarget 8:58, pages 98200-98214.
Crossref
Yahiya Y. Syed. (2017) Lenalidomide: A Review in Newly Diagnosed Multiple Myeloma as Maintenance Therapy After ASCT. Drugs 77:13, pages 1473-1480.
Crossref
Antje Hoering, Brian Durie, Hongwei Wang & John Crowley. (2017) End points and statistical considerations in immuno-oncology trials: impact on multiple myeloma. Future Oncology 13:13, pages 1181-1193.
Crossref
Susan J. Lee & Ivan Borrello. 2016. Plasma Cell Dyscrasias. Plasma Cell Dyscrasias 207 225 .
A Rosko, C Hofmeister, D Benson, Y Efebera, Y Huang, J Gillahan, J C Byrd & C E Burd. (2015) Autologous hematopoietic stem cell transplant induces the molecular aging of T-cells in multiple myeloma. Bone Marrow Transplantation 50:10, pages 1379-1381.
Crossref
Muhammad A. Mir, Prashant Kapoor, Shaji Kumar, Shivlal Pandey, Angela Dispenzieri, Martha Q. Lacy, David Dingli, William Hogan, Francis Buadi, Suzanne Hayman, Manish Gandhi & Morie A. Gertz. (2015) Trends and Outcomes in Allogeneic Hematopoietic Stem Cell Transplant for Multiple Myeloma at Mayo Clinic. Clinical Lymphoma Myeloma and Leukemia 15:6, pages 349-357.e2.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.